Table 3 Recurrence patterns of patients who underwent cholecystectomy during the primary treatment (PDS or IDS, n = 48)
From: Significance of cholecystectomy in cytoreductive surgery for advanced ovarian cancer
Age | 53 (24–78) |
FIGO stage | |
I | 1 (2.0%) |
II | 0 (0.0%) |
III | 33 (68.8%) |
IV | 14 (29.2%) |
Residual disease status after primary treatment | |
NGR | 33 (68.8%) |
GR-1 | 14 (29.2%) |
GR-B | 1 (2.1%) |
Number of recurrences | 12 (25%) |
Location of recurrence | |
Lymph node | 5 (10.4%) |
Peritoneum | 3 (6.3%) |
Bowel mesentery | 2 (4.2%) |
Liver | 2 (4.2%) |
Lung | 1 (2.4%) |
Bone | 1 (2.4%) |
Porta-hepatis | 0 (0%) |